Cargando…

Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products

BACKGROUND: No systematic investigations have been conducted to assess the lung burden imposed by the chronic inhalation of silver nanoparticles (AgNPs) emitted by spray products. OBJECTIVE: The objective of this study was to formulate a study framework that integrates a probabilistic risk assessmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying-Fei, Wang, Wei-Ming, Chen, Chi-Yun, Lu, Tien-Hsuan, Liao, Chung-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407905/
https://www.ncbi.nlm.nih.gov/pubmed/30880973
http://dx.doi.org/10.2147/IJN.S171510
_version_ 1783401654250373120
author Yang, Ying-Fei
Wang, Wei-Ming
Chen, Chi-Yun
Lu, Tien-Hsuan
Liao, Chung-Min
author_facet Yang, Ying-Fei
Wang, Wei-Ming
Chen, Chi-Yun
Lu, Tien-Hsuan
Liao, Chung-Min
author_sort Yang, Ying-Fei
collection PubMed
description BACKGROUND: No systematic investigations have been conducted to assess the lung burden imposed by the chronic inhalation of silver nanoparticles (AgNPs) emitted by spray products. OBJECTIVE: The objective of this study was to formulate a study framework that integrates a probabilistic risk assessment scheme with a mechanistic lung burden model for the estimation of health risks associated with the long-term inhalation of AgNP-containing spray products. MATERIALS AND METHODS: A compartmentalized physiologically based alveolar deposition (PBAD) model was used to estimate AgNP lung burden. Dose–response relationships were established using nanotoxicity data sets obtained from rats (as a model organism). Weibull model-based thresholds of AgNP lung burden based on neutrophil-elevated inflammation bio-markers were estimated from Hill-based exposure–response relationships. Finally, the risks of lung disease posed by various AgNP-containing spray products were assessed. RESULTS: Conservative thresholds for the prevention of pulmonary disease were estimated as follows (mean ± SE): 34 nm AgNPs (0.32±0.22 mg) and 60 nm AgNPs (1.08±0.64 mg). Our results indicate that the risk probability was ~0.5 that the hazard quotient (HQ) estimates of deodorant with a count median diameter (CMD) ≈30 nm exceeded 1. The primary risk posed by AgNPs is transferred from the interstitial region to lymph nodes. Under the condition of 50% risk probability, the 97.5 percentile of HQ for the spray products were as follows: CMD ≈30 nm (~3.4) and CMD ≈60 nm (~1.1). CONCLUSION: Our application of the proposed risk assessment scheme to the results obtained in an in vivo animal model proved highly effective in elucidating the relationship between the characteristics of metallic NP-containing spray products and their corresponding toxicity. The integration of the proposed PBAD model with a risk assessment framework enables the rapid assessment of risk posed by spray products containing metallic NPs over various time scales.
format Online
Article
Text
id pubmed-6407905
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64079052019-03-16 Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products Yang, Ying-Fei Wang, Wei-Ming Chen, Chi-Yun Lu, Tien-Hsuan Liao, Chung-Min Int J Nanomedicine Original Research BACKGROUND: No systematic investigations have been conducted to assess the lung burden imposed by the chronic inhalation of silver nanoparticles (AgNPs) emitted by spray products. OBJECTIVE: The objective of this study was to formulate a study framework that integrates a probabilistic risk assessment scheme with a mechanistic lung burden model for the estimation of health risks associated with the long-term inhalation of AgNP-containing spray products. MATERIALS AND METHODS: A compartmentalized physiologically based alveolar deposition (PBAD) model was used to estimate AgNP lung burden. Dose–response relationships were established using nanotoxicity data sets obtained from rats (as a model organism). Weibull model-based thresholds of AgNP lung burden based on neutrophil-elevated inflammation bio-markers were estimated from Hill-based exposure–response relationships. Finally, the risks of lung disease posed by various AgNP-containing spray products were assessed. RESULTS: Conservative thresholds for the prevention of pulmonary disease were estimated as follows (mean ± SE): 34 nm AgNPs (0.32±0.22 mg) and 60 nm AgNPs (1.08±0.64 mg). Our results indicate that the risk probability was ~0.5 that the hazard quotient (HQ) estimates of deodorant with a count median diameter (CMD) ≈30 nm exceeded 1. The primary risk posed by AgNPs is transferred from the interstitial region to lymph nodes. Under the condition of 50% risk probability, the 97.5 percentile of HQ for the spray products were as follows: CMD ≈30 nm (~3.4) and CMD ≈60 nm (~1.1). CONCLUSION: Our application of the proposed risk assessment scheme to the results obtained in an in vivo animal model proved highly effective in elucidating the relationship between the characteristics of metallic NP-containing spray products and their corresponding toxicity. The integration of the proposed PBAD model with a risk assessment framework enables the rapid assessment of risk posed by spray products containing metallic NPs over various time scales. Dove Medical Press 2019-03-05 /pmc/articles/PMC6407905/ /pubmed/30880973 http://dx.doi.org/10.2147/IJN.S171510 Text en © 2019 Yang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Yang, Ying-Fei
Wang, Wei-Ming
Chen, Chi-Yun
Lu, Tien-Hsuan
Liao, Chung-Min
Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products
title Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products
title_full Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products
title_fullStr Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products
title_full_unstemmed Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products
title_short Assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products
title_sort assessing human exposure risk and lung disease burden posed by airborne silver nanoparticles emitted by consumer spray products
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407905/
https://www.ncbi.nlm.nih.gov/pubmed/30880973
http://dx.doi.org/10.2147/IJN.S171510
work_keys_str_mv AT yangyingfei assessinghumanexposureriskandlungdiseaseburdenposedbyairbornesilvernanoparticlesemittedbyconsumersprayproducts
AT wangweiming assessinghumanexposureriskandlungdiseaseburdenposedbyairbornesilvernanoparticlesemittedbyconsumersprayproducts
AT chenchiyun assessinghumanexposureriskandlungdiseaseburdenposedbyairbornesilvernanoparticlesemittedbyconsumersprayproducts
AT lutienhsuan assessinghumanexposureriskandlungdiseaseburdenposedbyairbornesilvernanoparticlesemittedbyconsumersprayproducts
AT liaochungmin assessinghumanexposureriskandlungdiseaseburdenposedbyairbornesilvernanoparticlesemittedbyconsumersprayproducts